Baseline Characteristics of Study Population in Malaria Vaccine Studies, 2009–2014
| Characteristic . | Value . |
|---|---|
| Follow-up time, y, mean (median; range) | 3.02 (3.34; 0.01–4.50) |
| Age at enrollment | |
| 6 wk–4 mo | 838 (49.4) |
| 5–17 mo | 858 (50.6) |
| Sex, female | 50.4% |
| HIV status | |
| Uninfected | 1444 (85.1) |
| Infected | 131 (7.7) |
| Unknown | 121 (7.1) |
| Nutritional status at enrollment | |
| Mean weight-for-age z score (range) | −0.69 (−5.4 to 3.4) |
| Mean height-for-age z score (range) | −1.0 (−7 to 5) |
| Hemoglobin, g/dL | |
| Mean (range) | 10.8 (5.1–17.9) |
| <8 g/dL | 116 (6.8) |
| Characteristic . | Value . |
|---|---|
| Follow-up time, y, mean (median; range) | 3.02 (3.34; 0.01–4.50) |
| Age at enrollment | |
| 6 wk–4 mo | 838 (49.4) |
| 5–17 mo | 858 (50.6) |
| Sex, female | 50.4% |
| HIV status | |
| Uninfected | 1444 (85.1) |
| Infected | 131 (7.7) |
| Unknown | 121 (7.1) |
| Nutritional status at enrollment | |
| Mean weight-for-age z score (range) | −0.69 (−5.4 to 3.4) |
| Mean height-for-age z score (range) | −1.0 (−7 to 5) |
| Hemoglobin, g/dL | |
| Mean (range) | 10.8 (5.1–17.9) |
| <8 g/dL | 116 (6.8) |
Data are presented as No. (%) unless otherwise specified.
Abbreviation: HIV, human immunodeficiency virus.
Baseline Characteristics of Study Population in Malaria Vaccine Studies, 2009–2014
| Characteristic . | Value . |
|---|---|
| Follow-up time, y, mean (median; range) | 3.02 (3.34; 0.01–4.50) |
| Age at enrollment | |
| 6 wk–4 mo | 838 (49.4) |
| 5–17 mo | 858 (50.6) |
| Sex, female | 50.4% |
| HIV status | |
| Uninfected | 1444 (85.1) |
| Infected | 131 (7.7) |
| Unknown | 121 (7.1) |
| Nutritional status at enrollment | |
| Mean weight-for-age z score (range) | −0.69 (−5.4 to 3.4) |
| Mean height-for-age z score (range) | −1.0 (−7 to 5) |
| Hemoglobin, g/dL | |
| Mean (range) | 10.8 (5.1–17.9) |
| <8 g/dL | 116 (6.8) |
| Characteristic . | Value . |
|---|---|
| Follow-up time, y, mean (median; range) | 3.02 (3.34; 0.01–4.50) |
| Age at enrollment | |
| 6 wk–4 mo | 838 (49.4) |
| 5–17 mo | 858 (50.6) |
| Sex, female | 50.4% |
| HIV status | |
| Uninfected | 1444 (85.1) |
| Infected | 131 (7.7) |
| Unknown | 121 (7.1) |
| Nutritional status at enrollment | |
| Mean weight-for-age z score (range) | −0.69 (−5.4 to 3.4) |
| Mean height-for-age z score (range) | −1.0 (−7 to 5) |
| Hemoglobin, g/dL | |
| Mean (range) | 10.8 (5.1–17.9) |
| <8 g/dL | 116 (6.8) |
Data are presented as No. (%) unless otherwise specified.
Abbreviation: HIV, human immunodeficiency virus.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
